Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Abbott LaboratoriesABT |
$1.08B |
 |
Tempus AITEM |
-$130B |
 |
SolventumSOLV |
-$1.88B |
 |
TeleflexTFX |
$7.4M |
 |
Universal Health ServicesUHS |
-$21M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| KUEHN KURT P | Mar 10, 2026 | Sell | 2,844 | $78.961 | $220,000 |
| LASKAWY PHILIP A | Mar 5, 2026 | Sell | 2,844 | $80.36 | $230,000 |
| MLOTEK MARK E | Mar 4, 2026 | Sell | 4,100 | $80.795 | $330,000 |
| MLOTEK MARK E | Mar 4, 2026 | Sell | 1,825 | $80.811 | $150,000 |
| BERGMAN STANLEY M | Mar 2, 2026 | Sell | 23,858 | $81.31 | $1.9M |
| BERGMAN STANLEY M | Mar 2, 2026 | Sell | 19,954 | $81.31 | $1.6M |
| BERGMAN STANLEY M | Feb 27, 2026 | Sell | 10,785 | $81.2 | $880,000 |
| BERGMAN STANLEY M | Feb 26, 2026 | Sell | 31,134 | $80.9 | $2.5M |
| BERGMAN STANLEY M | Feb 26, 2026 | Sell | 7,212 | $81.51 | $590,000 |
| DANIEL WILLIAM K | Aug 7, 2025 | Buy | 10,000 | $67.08 | $670,000 |
| LASKAWY PHILIP A | Mar 19, 2025 | Sell | 2,604 | $71.044 | $180,000 |
| Connett Bradford C | Mar 19, 2025 | Sell | 4,036 | $71.15 | $290,000 |
| KUEHN KURT P | Mar 5, 2025 | Sell | 2,787 | $71.545 | $200,000 |
| Ettinger Michael S | Nov 18, 2024 | Sell | 12,240 | $75 | $920,000 |
| McGlynn Lorelei | Sep 6, 2024 | Sell | 21,035 | $69.3 | $1.5M |
| MLOTEK MARK E | Aug 14, 2024 | Sell | 3,000 | $69.12 | $210,000 |
| Siegel Walter | Jun 6, 2024 | Sell | 4,134 | $69.47 | $290,000 |
| Connett Bradford C | Mar 20, 2024 | Sell | 6,430 | $74.28 | $480,000 |
| BRESLAWSKI JAMES P | Mar 18, 2024 | Sell | 2,907 | $74.37 | $220,000 |
FAQ - Insider Transactions
The most recent insider transaction for Henry Schein was conducted by KUEHN KURT P, who sold 2,844 shares on March 10, 2026 at a price of $78.96 per share.
DANIEL WILLIAM K has bought the most HSIC stock in the last 2 years, with a total value of $670,000.
BERGMAN STANLEY M has sold the most HSIC stock in the last 2 years, with a total value of $7.5M.
The total value of insider transactions for Henry Schein in the last 2 years is negative, amounting to -$12M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Henry Schein have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
